FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

372489005: Granisetron (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1197782010 Granisetron (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1211024016 Granisetron en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
815241000172111 granisétron fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Belgian module (core metadata concept)
815251000172113 granisetron nl Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Belgian module (core metadata concept)

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Granisetron (substance) Is a 5-HT3 receptor antagonist true Inferred relationship Some
Granisetron (substance) Is a Azabicyclo compound (substance) true Inferred relationship Some
Granisetron (substance) Has disposition (attribute) 5-HT3 receptor antagonist true Inferred relationship Some
Granisetron (substance) Is a Drug allergen false Inferred relationship Some
Granisetron (substance) Is a Amide true Inferred relationship Some
Granisetron (substance) Is a Indazole (substance) true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Granisetron hydrochloride Is a False Granisetron (substance) Inferred relationship Some
Product containing granisetron (medicinal product) Has active ingredient True Granisetron (substance) Inferred relationship Some 1
Granisetron 1mg/mL injection concentrate 3mL ampule Has active ingredient False Granisetron (substance) Inferred relationship Some
Product containing precisely granisetron (as granisetron hydrochloride) 1 milligram/1 each conventional release oral tablet (clinical drug) Has active ingredient False Granisetron (substance) Inferred relationship Some
Granisetron 1mg/1mL intravenous solution Has active ingredient False Granisetron (substance) Inferred relationship Some
Granisetron 200micrograms/mL pediatric liquid Has active ingredient False Granisetron (substance) Inferred relationship Some
Granisetron (as granisetron hydrochloride) 2 mg oral tablet Has active ingredient False Granisetron (substance) Inferred relationship Some
Granisetron hydrochloride 1mg/1mL injection solution 1mL vial Has active ingredient False Granisetron (substance) Inferred relationship Some
Granisetron hydrochloride 1mg/1mL injection solution 4mL vial Has active ingredient False Granisetron (substance) Inferred relationship Some
Granisetron 0.1mg/mL injection solution 1mL vial Has active ingredient False Granisetron (substance) Inferred relationship Some
Granisetron-containing product in oral dose form Has active ingredient True Granisetron (substance) Inferred relationship Some 1
Product containing granisetron in parenteral dose form (medicinal product form) Has active ingredient True Granisetron (substance) Inferred relationship Some 1
Granisetron 3.1mg/24hours transdermal patch Has active ingredient False Granisetron (substance) Inferred relationship Some
Product containing precisely granisetron (as granisetron hydrochloride) 1 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) True Granisetron (substance) Inferred relationship Some 1
Granisetron (as granisetron hydrochloride) 2 mg oral tablet Has basis of strength substance (attribute) True Granisetron (substance) Inferred relationship Some 1
Granisetron hydrochloride Is modification of (attribute) True Granisetron (substance) Inferred relationship Some
Granisetron-containing product in transdermal dose form Has active ingredient True Granisetron (substance) Inferred relationship Some 1
Product containing precisely granisetron 129.167 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has precise active ingredient True Granisetron (substance) Inferred relationship Some 1
Product containing precisely granisetron 129.167 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has basis of strength substance (attribute) True Granisetron (substance) Inferred relationship Some 1
Product containing precisely granisetron (as granisetron hydrochloride) 200 microgram/1 milliliter conventional release oral solution (clinical drug) Has basis of strength substance (attribute) True Granisetron (substance) Inferred relationship Some 1
Product containing precisely granisetron (as granisetron hydrochloride) 3 milligram/3 milliliter conventional release solution for injection ampule Has basis of strength substance (attribute) False Granisetron (substance) Inferred relationship Some 1
Product containing precisely granisetron (as granisetron hydrochloride) 1 milligram/1 milliliter conventional release solution for injection ampule Has basis of strength substance (attribute) False Granisetron (substance) Inferred relationship Some 1
Granisetron only product Has active ingredient True Granisetron (substance) Inferred relationship Some 1
Product containing only granisetron in oral dose form (medicinal product form) Has active ingredient True Granisetron (substance) Inferred relationship Some 1
Granisetron only product in parenteral dose form Has active ingredient True Granisetron (substance) Inferred relationship Some 1
Granisetron only product in transdermal dose form Has active ingredient True Granisetron (substance) Inferred relationship Some 1
Granisetron (as granisetron hydrochloride) 1 mg/mL solution for injection Has basis of strength substance (attribute) True Granisetron (substance) Inferred relationship Some 1

Reference Sets

Belgian subset for AllergyIntolerance, causative agent, drug

Back to Start